News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2024 Shelley Wood April 30, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI L.A. McKeown April 24, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Conference News ISC 2024 Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA Todd Neale February 09, 2024